Ibrahim Abubakar is Vice Provost (Health) and Professor of Infectious Disease Epidemiology at UCL. Prior to his current role, he held multiple leadership positions at UCL including Pro-Provost (Health), Dean of the Faculty of Population Health Sciences, and Director of the Institute for Global Health. He led the UCL Centre for Infectious Disease Epidemiology, UCL-TB and was a senior investigator at the MRC Clinical Trials Unit. He was head of TB at Public Health England and was a Professor in Health Protection at the Norwich Medical School. He is a member of the Global Preparedness Monitoring Board, University College Hospitals NHS Trust Board, UCL Partners Board and the Board of Resolve to Save Lives. He is the chair of Lancet Migration: global collaboration to advance migration health. He was elected Fellow of the Academy of Medical Sciences in 2020, member of the German Academy of Sciences Leopoldina in 2024 and member of the US National Academy of Medicine in 2025. He was appointed NIHR Senior Investigator Emeritus in 2025. Previous roles include chairing the WHO Clinical Trials Forum, the WHO Strategic and Technical Advisory Group for Tuberculosis until 2019, Wellcome Trust Expert Review Group on Population Health until 2022 and the NIHR Global Health Professorship Committee until 2025. Ibrahim Abubakar現任倫敦大學學院副教務長（健康）及傳染病流行病學教授。 出任現職前，他曾在校內擔任多個領導職位，包括協理副教務長（健康）、人口健康科學學院院長 及全球健康研究所所長。他曾領導倫敦大學學院傳染病流行病學中心及結核病研究網絡，亦曾任 英國醫學研究理事臨床試驗中心高級研究員。此外，他曾任英格蘭公共衞生署結核病主管， 以及Norwich Medical School衞生防護學教授。 他現為全球防範工作監測委員會委員，並出任倫敦大學學院醫院國民保健署信託、倫敦大學學院 夥伴聯盟及Resolve to Save Lives的董事會成員，同時擔任《The Lancet》移民健康全球合作 計劃主席。他於2020年當選英國醫學科學院院士，2024年當選德國國家科學院院士，2025年 當選美國國家醫學院院士，同年獲頒英國國家健康研究院榮休高級研究員名銜。 他亦曾擔任世衞臨床試驗論壇主席、世衞結核病策略及技術諮詢小組主席（至2019年）、惠康 基金會人口健康專家評審小組主席（至2022年），以及英國國家健康研究院全球健康教授席 委員會主席（至2025年）。 Ibrahim ABUBAKAR Vice-Provost (Health) University College London 倫敦大學學院副教務長（健康） 27
RkJQdWJsaXNoZXIy NDk5Njg=